◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HSBC Asia Pacific Ex Japan Screened Equity UCITS ETF (HSXJ) ETF Overview

Name: HSBC Asia Pacific Ex Japan Screened Equity UCITS ETF (HSXJ) price history and fund statistics
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Price history, fund statistics and profile — an exchange-traded fund.

Exchange-Traded Funds · DATA UPDATED 2026-09-01

HSBC Asia Pacific Ex Japan Screened Equity UCITS ETF (HSXJ) is an exchange-traded fund managed by HSBC Investment Funds (Luxembourg) S.A.. It manages roughly £656 million in assets.

Interactive chart & fund stats →

HSXJ Fund Statistics

Expense ratio	0.25%
Assets under management	£656 million
Fund family	HSBC Investment Funds (Luxembourg) S.A.
Inception	2022-07-05

The live price chart, fund profile and news are in the interactive HSXJ viewer.

Other Companies in —

IUCB · State Street SPDR Bloomberg 1-10 Year U.S. Corporate Bond UCITS ETF — $664 million
SYBR · State Street SPDR Bloomberg 1-10 Year U.S. Corporate Bond UCITS ETF — €664 million
CU31 · iShares VII PLC - iShares $ Treasury Bd 1-3y ETF USD Acc B — £658 million
H4Z2 · HSBC Asia Pacific Ex Japan Screened Equity UCITS ETF — €656 million
DELF · L&G MSCI Europe Select UCITS ETF - EUR Accumulating ETF — €651 million
RIEG · L&G MSCI Europe Select UCITS ETF - EUR Accumulating ETF — £651 million
EXSG · iShares EURO STOXX Select Dividend 30 UCITS ETF (DE) — €648 million
D6RQ · Deka MSCI USA Climate Change ESG CTB UCITS ETF — €648 million

← HSXE All “H” companies HSY →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.